Retatrutide
Retatrutide
(10 mg)
Retatrutide is a triple receptor agonist (GIP, GLP-1, and glucagon) currently under investigation in metabolic research for its effects on energy balance and body weight regulation.
$110.00
Description
Retatrutide is a triple-agonist peptide acting on GLP-1, GIP, and glucagon receptors, positioning it at the cutting edge of metabolic research. Studies have examined its effects on energy expenditure, fat oxidation, and weight-related endpoints with results that have generated considerable interest in the research community. Because retatrutide engages three distinct receptor pathways, it offers a research profile no other commercially available peptide currently matches. Manufactured to pharmaceutical-grade purity. For research and laboratory use only.
